Stock Earnings

Question 1

Quels sont les états financiers clés de CanSino Biologics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), CanSino Biologics Inc a un total d'actifs de $7,958, un bénéfice net loss de $-378

Question 2

Quels sont les ratios financiers clés pour CASBF ?

Accepted Answer

Le ratio de liquidité de CanSino Biologics Inc est 2.61, la marge nette est -44.68, les ventes par action sont de $3.41.

Question 3

Comment les revenus de CanSino Biologics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

CanSino Biologics Inc largest revenue segment is Vaccines and Related Products, at a revenue of 800,341,058 in the most earnings release.For geography, China is the primary market for CanSino Biologics Inc, at a revenue of 795,161,429.

Question 4

CanSino Biologics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, CanSino Biologics Inc a un bénéfice net loss de $-378

Question 5

CanSino Biologics Inc a-t-elle des passifs ?

Accepted Answer

yes, CanSino Biologics Inc a un passif de 3,048

Question 6

Combien d'actions en circulation CanSino Biologics Inc a-t-elle ?

Accepted Answer

CanSino Biologics Inc a un total d'actions en circulation de 230.72

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	971	846	357	1,034	4,299	18
Revenue Growth (YoY)	30%	137%	-65%	-76%	23,783%	--
Cost of Revenue	205	257	800	1,218	1,297	13
Gross Profit	765	589	-443	-183	3,001	4
Selling, General & Admin	634	534	620	545	326	95
Research & Development	368	335	568	731	850	408
Operating Expenses	950	937	1,245	1,274	1,203	413
Other Non Operating Income (Expenses)	-3	-6	-42	-3	-3	0
Pretax Income	-147	-381	-1,978	-1,184	1,936	-396
Income Tax Expense	-4	2	-11	-219	29	0
Net Income	-142	-378	-1,482	-909	1,914	-396
Net Income Growth	-80%	-74%	63%	-147%	-583%	154%
Shares Outstanding (Diluted)	202.93	247.44	246.71	247.12	247.33	230.92
Shares Change (YoY)	-18%	0%	0%	0%	7%	14%
EPS (Diluted)	-0.69	-1.53	-6.01	-3.68	7.74	-1.72
EPS Growth	-76%	-75%	63%	-148%	-550%	123%
Free Cash Flow	-156	-624	-1,518	-2,926	846	-740
Free Cash Flow Per Share	-0.76	-2.52	-6.15	-11.84	3.42	-3.2
Gross Margin	78.78%	69.62%	-124.08%	-17.69%	69.8%	22.22%
Operating Margin	-19.05%	-41.13%	-473.1%	-140.9%	41.82%	-2,266.66%
Profit Margin	-14.62%	-44.68%	-415.12%	-87.91%	44.52%	-2,200%
Free Cash Flow Margin	-16.06%	-73.75%	-425.21%	-282.97%	19.67%	-4,111.11%
EBITDA	--	-234	-1,578	-1,402	1,838	-377
EBITDA Margin	--	-27.65%	-442.01%	-135.58%	42.75%	-2,094.44%
D&A For EBITDA	--	114	111	55	40	31
EBIT	-185	-348	-1,689	-1,457	1,798	-408
EBIT Margin	-19.05%	-41.13%	-473.1%	-140.9%	41.82%	-2,266.66%
Effective Tax Rate	2.72%	-0.52%	0.55%	18.49%	1.49%	0%

CanSino Biologics Inc (CASBF) Price

CASBF Stock Price Chart

CASBF Income

Follow-Up Questions